Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/105636
Tumor cell dormancy
Journal Title
Authors
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Metastasis is the primary cause of death in cancer patients and current treatments fail to provide durable responses. Efforts to treat metastatic disease are hindered by the fact that metastatic cells often remain dormant for prolonged intervals of years, or even decades. Tumor dormancy reflects the capability of disseminated tumor cells (DTCs), or micrometastases, to evade treatment and remain at low numbers after primary tumor resection. Unfortunately, dormant cells will eventually produce overt metastasis. Innovations are needed to understand metastatic dormancy and improve cancer detection and treatment. Currently, few models exist that faithfully recapitulate metastatic dormancy and metastasis to clinically relevant tissues, such as the bone. Herein, we discuss recent advances describing genetic cell-autonomous and systemic or local changes in the microenvironment that have been shown to endow DTCs with properties to survive and eventually colonize distant organs.
Subject
Subject (English)
Citation
Citation
GOMIS I CABRÉ, Roger and GAWRZAK, Sylwia. Tumor cell dormancy. Molecular Oncology. 2016. Vol. vol 11, num. 1, pags. 62-78. ISSN 1878-0261. [consulted: 13 of June of 2026]. Available at: https://hdl.handle.net/2445/105636